1. Samet JM. Tobacco smoking: the leading cause of preventable disease worldwide. Thorac Surg Clin 2013;23:103-12.

2. Trichopoulos D, Kalandidi A, Sparros L, MacMahon B. Lung cancer and passive smoking. Int J Cancer 1981;27:1-4.

3. Li K, Yao C, Di X, Yang X, Dong L, Xu L, et al. Smoking and risk of all-cause deaths in younger and older adults: a populationbased prospective cohort study among Beijing adults in China. Medicine (Baltimore) 2016;95:e2438.

4. Maag J, Braun J, Bopp M, Faeh D; Swiss National Cohort. Direct estimation of death attributable to smoking in Switzerland based on record linkage of routine and observational data. Nicotine Tob Res 2013;15:1588-97.

5. Park YS, Park S, Lee CH. The attributable risk of smoking on all-cause mortality in Korean: a study using KNHANES IV-VI (2007-2015) with mortality data. Tuberc Respir Dis 2020 Jul 7[Epub]. https://doi.org/10.4046/trd.2020.0006.

6. Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013;368:341-50.

7. Foulds J, Schmelzer AC, Steinberg MB. Treating tobacco dependence as a chronic illness and a key modifiable predictor of disease. Int J Clin Pract 2010;64:142-6.

8. Kwon DS, Kim TH, Byun MK, Kim HJ, Lee HS, Park HJ, et al. Positive effects of the national cigarette price increase policy on smoking cessation in South Korea. Tuberc Respir Dis 2020;83:71-80.

9. Chamberlain C, O’Mara-Eves A, Porter J, Coleman T, Perlen SM, Thomas J, et al. Psychosocial interventions for supporting women to stop smoking in pregnancy. Cochrane Database Syst Rev 2017;2:CD001055.

10. Chun EM. Smoking cessation strategies targeting specific populations. Tuberc Respir Dis 2019;82:1-5.

11. Kim T, Cha YJ, Chang YS. Correlation of PD-L1 expression tested by 22C3 and SP263 in non-small cell lung cancer and its prognostic effect on EGFR mutation-positive lung adenocarcinoma. Tuberc Respir Dis 2020;83:51-60.